10-KPeriod: FY2014

Philip Morris International Inc. Annual Report, Year Ended Dec 31, 2014

Filed February 20, 2015For Securities:PM

Summary

Philip Morris International Inc. (PMI) for the year ending December 31, 2014, demonstrated resilience despite facing significant currency headwinds and restructuring charges. While net revenues remained relatively flat year-over-year, a substantial decline in diluted EPS was primarily driven by unfavorable currency movements, particularly impacting the Argentine peso, Australian dollar, Canadian dollar, Euro, Indonesian rupiah, Japanese yen, Kazakhstan tenge, Russian ruble, Turkish lira, and the Ukraine hryvnia. The company also incurred significant asset impairment and exit costs related to factory closures and restructuring initiatives. Despite these challenges, PMI continued to execute its pricing strategies, which helped offset some of the negative impacts on operating income. The company also made strategic acquisitions, including Nicocigs Limited, to expand its presence in the e-vapor market. Looking ahead, PMI provided guidance for 2015, forecasting a decline in reported diluted EPS, largely due to continued currency pressures. However, the company emphasized its focus on innovation, particularly with its reduced-risk product (RRP) portfolio, including iQOS, signaling a strategic shift towards developing and commercializing products with the potential to reduce individual risk and population harm.

Financial Statements
Beta

Key Highlights

  • 1Net revenues were largely flat at $80.1 billion in 2014 compared to $80.0 billion in 2013, but excluding excise taxes, net revenues decreased by 4.6% to $29.8 billion due to unfavorable currency movements and volume/mix, partially offset by price increases.
  • 2Diluted earnings per share (EPS) decreased by 9.5% to $4.76 in 2014 from $5.26 in 2013, significantly impacted by unfavorable currency movements (which reduced EPS by $0.80) and asset impairment/exit costs ($0.26 per share).
  • 3The company recorded pre-tax asset impairment and exit costs of $535 million in 2014, primarily related to factory closures in the Netherlands, Australia, and Canada, and restructuring of its U.S. leaf purchasing model.
  • 4Total cigarette shipment volume decreased by 2.8% in 2014, with notable declines in the EEMA and Asia regions, although market share increased or remained flat in several key markets.
  • 5PMI acquired Nicocigs Limited, a UK-based e-vapor company, for $103 million plus contingent payments, as part of its strategy to develop reduced-risk products (RRPs).
  • 6Despite a challenging operating environment, PMI continued to return capital to shareholders, with dividends declared per share increasing to $3.88 in 2014 from $3.58 in 2013.
  • 7The company is actively developing a portfolio of reduced-risk products (RRPs), including the iQOS heated tobacco product, which was launched in pilot cities in Japan and Italy in late 2014.

Frequently Asked Questions

The primary drivers of the decline in diluted EPS from $5.26 in 2013 to $4.76 in 2014 were unfavorable currency movements, which negatively impacted EPS by $0.80, and asset impairment and exit costs of $0.26 per share, primarily related to factory closures and restructuring.

PMI is strategically focused on developing, assessing, and commercializing a portfolio of RRPs. This includes investing in heated tobacco products like iQOS, as well as e-vapor products. The company is conducting rigorous scientific studies to substantiate potential reduced exposure and risk claims, aiming to provide adult smokers with alternatives to combustible cigarettes.

Currency fluctuations had a significant negative impact on PMI's financial results in 2014. The strengthening U.S. dollar against various currencies, including the Argentine peso, Euro, Japanese yen, and Russian ruble, decreased reported net revenues by $5.3 billion and operating income by $1.5 billion. This unfavorable currency impact also reduced diluted EPS by $0.80.

In 2014, PMI incurred pre-tax asset impairment and exit costs of $535 million. These charges were primarily related to the discontinuation of cigarette production at its factory in the Netherlands, factory closures in Australia and Canada, and the restructuring of its U.S. leaf purchasing model.